Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions

BACKGROUND: Patients with malignant mesothelioma have a poor prognosis and only 40% respond to first line treatment; a combination of pemetrexed and cisplatin or carboplatin. We used primary malignant mesothelioma cells and an ex vivo chemosensitivity assay with future purpose to predict best choice...

Descripción completa

Detalles Bibliográficos
Autores principales: Szulkin, Adam, Ötvös, Rita, Hillerdal, Carl-Olof, Celep, Aytekin, Yousef-Fadhel, Eviane, Skribek, Henriette, Hjerpe, Anders, Székely, László, Dobra, Katalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190467/
https://www.ncbi.nlm.nih.gov/pubmed/25253633
http://dx.doi.org/10.1186/1471-2407-14-709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190467/
https://www.ncbi.nlm.nih.gov/pubmed/25253633
http://dx.doi.org/10.1186/1471-2407-14-709

Ejemplares similares